GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » Cyclically Adjusted Book per Share

YIFAN PHARMACEUTICAL CO (SZSE:002019) Cyclically Adjusted Book per Share : ¥5.49 (As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's adjusted book value per share for the three months ended in Mar. 2024 was ¥6.858. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ¥5.49 for the trailing ten years ended in Mar. 2024.

During the past 12 months, YIFAN PHARMACEUTICAL CO's average Cyclically Adjusted Book Growth Rate was 12.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 15.60% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 16.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of YIFAN PHARMACEUTICAL CO was 21.30% per year. The lowest was 10.20% per year. And the median was 17.90% per year.

As of today (2024-05-27), YIFAN PHARMACEUTICAL CO's current stock price is ¥13.50. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was ¥5.49. YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio of today is 2.46.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of YIFAN PHARMACEUTICAL CO was 15.38. The lowest was 1.88. And the median was 6.31.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted Book per Share Historical Data

The historical data trend for YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

YIFAN PHARMACEUTICAL CO Cyclically Adjusted Book per Share Chart

YIFAN PHARMACEUTICAL CO Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.96 3.44 4.05 4.72 5.32

YIFAN PHARMACEUTICAL CO Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.88 5.01 5.20 5.32 5.49

Competitive Comparison of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio falls into.



YIFAN PHARMACEUTICAL CO Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, YIFAN PHARMACEUTICAL CO's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=6.858/115.2271*115.2271
=6.858

Current CPI (Mar. 2024) = 115.2271.

YIFAN PHARMACEUTICAL CO Quarterly Data

Book Value per Share CPI Adj_Book
201406 1.118 98.200 1.312
201409 2.197 98.900 2.560
201412 2.311 99.000 2.690
201503 2.388 99.900 2.754
201506 2.467 99.500 2.857
201509 2.536 100.500 2.908
201512 2.596 100.600 2.973
201603 2.721 102.200 3.068
201606 2.888 101.400 3.282
201609 3.045 102.400 3.426
201612 3.202 102.600 3.596
201703 3.385 103.200 3.779
201706 3.523 103.100 3.937
201709 5.005 104.100 5.540
201712 5.359 104.500 5.909
201803 5.631 105.300 6.162
201806 5.658 104.900 6.215
201809 5.464 106.600 5.906
201812 5.488 106.500 5.938
201903 5.607 107.700 5.999
201906 5.684 107.700 6.081
201909 5.917 109.800 6.209
201912 6.063 111.200 6.283
202003 6.354 112.300 6.520
202006 6.633 110.400 6.923
202009 6.792 111.700 7.006
202012 6.828 111.500 7.056
202103 6.981 112.662 7.140
202106 6.988 111.769 7.204
202109 7.010 112.215 7.198
202112 6.917 113.108 7.047
202203 7.013 114.335 7.068
202206 6.992 114.558 7.033
202209 7.162 115.339 7.155
202212 7.188 115.116 7.195
202303 7.226 115.116 7.233
202306 7.326 114.558 7.369
202309 7.329 115.339 7.322
202312 6.750 114.781 6.776
202403 6.858 115.227 6.858

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


YIFAN PHARMACEUTICAL CO  (SZSE:002019) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

YIFAN PHARMACEUTICAL CO's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=13.50/5.49
=2.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of YIFAN PHARMACEUTICAL CO was 15.38. The lowest was 1.88. And the median was 6.31.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


YIFAN PHARMACEUTICAL CO Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines